Integration of AYUSH Systems in National Healthcare Framework
Plain-language summary (AI-generated) — a quick read so you don't have to open the full PDF. May contain errors; the original document below is authoritative.
What was asked, and of whom?
The question asked for steps taken by the government to integrate AYUSH systems into the national healthcare framework, including co-location in health facilities, research, and quality control of AYUSH medicines. The Ministry of Ayush provided the answer.
Who asked / answered
Shri P P Chaudhary, Shri Pratap Chandra Sarangi (asked); Ministry of Ayush (answered)
What the government said
- Co-location of AYUSH services in 13,249 health facilities (PHCs: 6,302, CHCs: 3,191, DHs: 475, other: 3,281) as of 31.12.2025
- 25,322 Ayush doctors and 5,666 Ayush paramedics deployed in States/UTs
- Ayush Vertical under DGHS for planning and monitoring Ayush-specific public health programs
- Integrated Ayush Departments in Central Government Hospitals (e.g., Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi)
- Ayush Module–Internship Electives for MBBS students in Ayurveda, Unani, Siddha
- Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) for quality standards
- 118 private and 34 State UT Drug Testing Laboratories for ASSU&H drugs
- Three-tier pharmacovigilance network: 1 National, 5 Intermediary, 97 Peripheral centers
- Ayush Suraksha portal for reporting Adverse Drug Reactions
- 12,500 Ayushman Arogya Mandirs (Ayush) supported for holistic healthcare
- Ayush Policy Roadmap for strategic development of Ayush sector
Points worth noting
- The answer does not provide State-wise and constituency-wise details for all parts of the question (a, b, c, d, e) as requested, only stating that such details are attached in annexures.
- The answer states that public health is a State subject, so the primary responsibility for tribal areas lies with State Governments, though the Ministry supports through NAM scheme.
- The answer mentions a three-tier pharmacovigilance network but does not provide specific figures on adverse drug reactions or effectiveness of Ayush interventions.
| Source body | Parliament of India — Questions & Answers (Lok Sabha, starred) |
| Reference number | LS Q98 (Session 8) |
| Status | closed (section: question) |
| Year | 24.0 |
| Closing date | — |
| Documents | 1 |
Highlights & Points worth asking
Auto-generated, neutral observations. Auto-generated from public documents. May contain errors. Not legal or financial advice. Always verify against the linked original document. KaunZimmedar is a platform, not an authority.
No automated observations for this document. Read the documents below directly.
Documents
The original government PDF is the authoritative source — shown below, or open it full-screen in a new tab.
Question
24.07.2026
ls18s8-q98.pdf
Tap “Open the PDF” above to view this document.
Discussion (0)
Citizens discussing these documents. A discussion space — nothing here is verified fact or an official finding. Reading is free; sign in to take part.
Open discussion (0) →